Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2018 | ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer | Petrossian K.; Kanaya N.; Chiao Lo ; Hsu P.-Y.; Nguyen D.; Yang L.; Yang L.; Warden C.; Wu X.; Pillai R.; Bernal L.; CHIUN-SHENG HUANG ; Kruper L.; Yuan Y.; Somlo G.; Mortimer J.; Chen S. | Oncotarget | 8 | 0 |